Font Size

Cpanel

Public Health Dynamics Seminars Archive

Monday, April 10 - Supervised Injection Facilities: From Models to Policies

Ahmed Bayoumi, MD, MSc

Professor, Department of Medicine and the Institute of Health Policy, Management and Evaluation
University of Toronto
Scientist, Centre for Research on Inner City Health, Li Ka Shing Knowledge Institute

Monday, April 10, 2017
12:00 – 1:00 PM
A521 Crabtree Hall – Pitt Public Health

View slides

Abstract:

A supervised consumption site is a legally sanctioned health facility that offers a hygienic environment where people can use illicit drugs under the supervision of trained staff. Although over 90 facilities have been implemented internationally to date, only two have been established in North America, both in Vancouver. There is renewed interest across Canada and the US in supervised injection given the current marked rise in opioid overdoses and related deaths. Dr. Bayoumi will discuss how the intersection of evidence, research, and policy moved the discussion of supervised injection in Toronto, Canada’s largest city, from a controversial idea to a widely supported policy recommendation with anticipated approval within the next few weeks. He will focus on how modeling can inform decisions about uncertain and controversial interventions and thoughts about conducting policy-relevant research that is controversial and value-laden.

About the speaker:

Ahmed Bayoumi, MD, MScDr. Ahmed Bayoumi is a Scientist at the Centre for Research on Inner City Health at the Li Ka Shing Knowledge Institute and a general internist and HIV physician at St. Michael's Hospital. He holds the Fondation Baxter & Alma Ricard Chair in Inner City Health at St. Michael’s and the University of Toronto. He is a Professor in the Department of Medicine and in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a past Director of Clinical Epidemiology and Health Care Research at the University of Toronto and a past president of the Society for Medical Decision Making. He is also a Senior Adjunct Scientist at the Institute for Clinical Evaluative Sciences and a member of the Canadian Drug Expert Committee.

His research interests include economic evaluation, decision analysis, and quality of life assessment for HIV-related health interventions, and studies of the access to the delivery of health services, particularly to people living with HIV, people who use drugs, and other marginalized populations. His work has included cost-effectiveness analyses of screening strategies for HIV, drug treatments for HIV and related conditions, and supervised injection facilities for injection drug users.

 

 

 

 

 

 

 

You are here: Home Seminar Series Archives Monday, April 10 - Supervised Injection Facilities: From Models to Policies